Stock Events

Stock Events

Search...

Acadia Pharmaceuticals (ACAD) Q4 2020 Earnings

4NovConfirmed

Q1 2020

Q2 2020

Q3 2020

Q4 2020

-0.57

-0.47

-0.37

-0.27

Details

Expected EPS

-0.39

Actual EPS

-0.54

Surprise EPS

-0.15

Surprise Percent

+38.46%

Description

Acadia Pharmaceuticals (ACAD) has reported earnings of -0.54 per share for Q4 2020.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.